绿叶制药因可转换债券获兑换而发行5291.94万股

Core Viewpoint - Green Leaf Pharmaceutical (02186) announced the issuance of ordinary shares in exchange for convertible bonds maturing in 2025, indicating a strategic move to manage debt and enhance equity capital [1] Group 1: Convertible Bonds Details - On September 10, 2025, the company will issue 31.75 million ordinary shares at an exchange price of HKD 3.672 per share in relation to the USD 15 million convertible bonds with a 5.85% interest rate [1] - Additionally, on the same date, the company will issue 21.17 million ordinary shares at the same exchange price for USD 10 million convertible bonds also with a 5.85% interest rate [1]